(PharmaNewsWire.Com, December 22, 2017 ) Nasal Drug Delivery Market is growing with the rapid pace; mainly due to the increasing demand for Nasal Drug and introduction of advanced technology. Middle East and Africa Nasal Drug Delivery Market to reach around $ 1.59 billion in 2022 growing at a CAGR of 8.1%; this market was worth $ 1 billion in 2015. Nasal Drug Delivery Market of Middle East and Africa’s Information, by Dosage Form (Drops, Sprays, Powder, Gels and Ointments), by System (Unit Dose, Multi-Dose and Metered Dose), by Delivery Technologies (Spray, Nebulizers and Other), by Therapeutic Applications (Rhinitis, Vaccinations, Congestion and Others) - Forecast till 2022. The intra-nasal route of drug administration is getting to be popular well known because of its noninvasive nature thereby reducing pain and threat of infections and allows the patient to self-administer drugs without any help from anyone.
Moreover recent research has also pointed its applications related to drug delivery to the brain. Bioavailability of a drug is defined as the proportion of a drug entering the systemic circulation as compared to the dosage. Nasal drug delivery eliminates drug destruction by HCL present in the stomach thereby increasing bioavailability which reduces the dosage of the drug. The reduction in dosage leads to proportional reduction in side effects. Growth of over the counter nasal drugs such as inhalers for common cold is also driving the market.
The market for nasal drug delivery is increasing at a good CAGR due to the above mentioned advantages of nasal drugs. Other market driving factors include ease of administration, growing efficacy of the route due to development of drugs which are absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which deliver a very precise dose.
Nasal drug delivery Market Companies Involved Are: Merck & Co., AptarGroup, Johnson & Johnson Services, GlaxoSmithKline Plc, Becton Dickson & Company, Novartis AG, Pfizer, Sanofi-Aventis.
Nasal drug delivery Market Segments:
On the basis of system, market is segmented into unit dose, multi-dose and metered dose.
Delivery technologies; market is segmented into spray, nebulizers and other.
Therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.
Nasal drug delivery Market of Middle East and Africa - Competitive Analysis
Characterized by the presence of several well-established players having regional and international presence, the Nasal drug delivery Market appears to be highly competitive yet consolidated.
Nasal drug delivery Market of Middle East and Africa - Study Aim
The market for nasal drug delivery is increasing at a good CAGR due to the above mentioned advantages of nasal drugs. Other market driving factors include ease of administration, growing efficacy of the route due to development of drugs which are absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which deliver a very precise dose.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market.
Table of Contents:
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Middle East and Africa Nasal Drug Delivery Market, By Dosage Form
6 Middle East and Africa Nasal Drug Delivery Market, By Basis of System
7 Middle East and Africa Nasal Drug Delivery Market, By Delivery Technologies
8 Middle East and Africa Nasal Drug Delivery Market, By Therapeutic Applications
9 Middle East and Africa Nasal Drug Delivery Market, By Country
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
